bibliographicCitation |
Carles J, Font A, Mellado B, Domenech M, Gallardo E, González-Larriba JL, Catalan G, Alfaro J, Gonzalez del Alba A, Nogué M, Lianes P, Tello JM. Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study. British Journal of Cancer. 2007 Oct 23;97(9):1206–10. doi: 10.1038/sj.bjc.6604030. |